Videra Health

Videra sells screening, documentation and QA modules

The vendor's headline is "The AI Platform Built for Behavioral Health. Clinical insight. Operationalized." Per the vendor, Assess sends the patient a text link, the patient answers by video, voice or chat, and models extract facial, voice, language and movement signals and alert the care team. The vendor says Assess "can predict PHQ-9, GAD-7, and PCL-5 scores from as little as one minute."

Per the vendor, Sidekick Notes writes ambient notes in individual and group sessions, with a Speaker Map that produces a separate note per group participant. The vendor claims 70% less admin time and 96% of notes signed with no amendments. Other modules cover supervision scoring, note checks before payor review, and chart prefill before session one. The vendor's science page lists AUC figures it describes as validated on independent test sets: 0.88 to 0.90 for PHQ-V, 0.90 for GAD-V, 0.85 to 0.90 for PCL-V, 0.89 for EPDS-V and 0.87 to 0.92 for a tardive dyskinesia video model.

Four company-authored papers, one on single-video screening

The largest paper (PMID 41402520, npj Digital Medicine 2025) enrolled 2,420 participants and tested whether one video answer can screen for PHQ-9, GAD-7 and PCL-5 outcomes, with an assessment 64.6% shorter (78.4 seconds against 221.7). The authors state they are Videra Health employees and that the company may implement the findings commercially. Further papers address postpartum depression screening with the EPDS (PMID 42539323) and tardive dyskinesia detection from video, in a 2026 study with external clinicians among the co-authors (PMID 42133936) and a 2025 Journal of Clinical Psychiatry paper. None of the four papers covers Sidekick Notes.

What does the FDA record show?

The Videra site shows an "FDA Registered" badge. The openFDA registration record lists VIDERA HEALTH in Orem, Utah, registration 3016372788, product code PTY ("Computerized Cognitive Assessment Aid, Exempt"), class 2, regulation 882.1470, created in December 2019 with a registration expiry year of 2026. No 510(k) or De Novo number appears for Videra.

Funding ran from a $3M seed in 2021 to a $5.6M Seed II in 2024

The company dates itself to 2019. The website states no headquarters, while the FDA registration and a PubMed affiliation list Orem, Utah. Funding was a $3M seed in November 2021 led by Peterson Ventures, then a $5.6M "Seed II" announced in May 2024 with Mercato Partners, Epic Ventures and Philo Ventures joining.

The home page claims "1,000+ Facilities" and a "64% reduction in crisis-driven interventions." The vendor lists HIPAA and SOC 2 Type II, with a public Trust Center, and its FAQ names Kipu Health among the integrated EHRs.

Where is the price?

No price is public. The home, Sidekick, Assess and FAQ pages all lead to "Book a Demo."

The verdict

A treatment facility on Kipu that wants patient screening and ambient notes under one contract is the buyer the demo-led process fits. A solo clinician or small practice comparing monthly prices has no figure to work from.